Bill focuses on advising clients through merger & acquisition transactions, recapitalizations, and strategic advisory. In addition to executing transactions on behalf of clients, Bill plays a key role in supporting Westcove’s origination efforts and expansion into new coverage areas.
Prior to joining Westcove, Bill worked with the investment banking team at Provident Healthcare Partners, where he originated and executed on transactions across multiple healthcare verticals, including healthcare services, pharmaceutical and life sciences services, and physician practice management. Bill has contributed to numerous national publications throughout his career, including Outsourced Pharma, Reuters, Becker’s, and AIS Health, among others.
Bill graduated from the University of Maryland, where he studied Economics. He holds his Series 63 and 79 FINRA licenses.
Westcove Partners spoke with Michael Ruane, Chief Executive Officer of The Prescription Center, to discuss his experience navigating a healthcare transaction. In this Q&A, he reflects on the decisions, challenges, and insights that shaped his journey.
Westcove Partners announced that it acted as the exclusive financial advisor to Topography Health in the sale of its clinical research assets to FOMAT Medical Research.
Building on Westcove Partners’ continued momentum, we are pleased to share our 2025 firmwide update.
Westcove Partners announced that it acted as the exclusive financial advisor to Tampa Bay Medical Research in its partnership with Alcanza Clinical Research.
Westcove Partners announced that it acted as the exclusive financial advisor to The Prescription Center in its partnership with Altruix.
Westcove Partners announced that it acted as the exclusive financial advisor to Coastal Research Institute in its partnership with Rovia Clinical Research.
Westcove Partners announced that it acted as the exclusive financial advisor to Cardiology Consultants of Philadelphia in its partnership with Cardiovascular Logistics.
In the spirt of keeping our industry partners apprised of Westcove’s initiatives, successes, and coverage areas, our team is excited to share our 2024 firmwide update.
Westcove Partners announced that it acted as the exclusive financial advisor to Williamsburg Dental in its partnership with Cordental Group.
Westcove Partners announced that it acted as the exclusive financial advisor to Altus Research in its partnership with Undisclosed Investor.
Westcove Partners announced that it acted as the exclusive financial advisor to Kansas City Research Institute in its partnership with Alcanza Clinical Research.
Westcove Partners announced that it acted as the exclusive financial advisor to Nextera Healthcare in its Partnership with Shore Capital Partners.
Westcove, through its Impact Investing initiative, made a strategic investment in Kodezi, a cutting-edge AI development platform.
In the spirt of keeping our industry partners apprised of Westcove’s initiatives, successes, and coverage areas, our team is excited to share our 2023 firmwide update.
Bill Bolding was promoted to Vice President and Geno Catalano joins as an Associate and Brandon Roberts joins as an Analyst.
In the spirt of keeping our industry partners apprised of Westcove’s initiatives, successes, and coverage areas, our team is excited to share our 2022 firmwide update.
Westcove, through its Impact Investing initiative, made a strategic investment in Chezie, a one-stop solution for employee resource groups.
Rebecca Phuong joins as Associate, and Fei Han and Andrew Nguyen join as Analysts.
An interview with Praveen Suthrum on Scope Forward.
Westcove expands team with addition of Bill Bolding as Associate.
In the spirt of keeping our industry partners apprised of Westcove’s initiatives, successes, and coverage areas, our team is excited to share our 2021 firmwide update.
Westcove, though its Impact Investing initiative, participates in $29.4 million Series A financing round.
